ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $405,000 | -19.3% | 8,733 | -75.2% | 0.08% | -32.7% |
Q4 2018 | $502,000 | +30.1% | 35,249 | +38.7% | 0.11% | +54.8% |
Q3 2018 | $386,000 | +70.8% | 25,413 | +83.6% | 0.07% | +52.1% |
Q1 2018 | $226,000 | +33.7% | 13,838 | +4.5% | 0.05% | +11.6% |
Q4 2017 | $169,000 | +59.4% | 13,238 | +5.3% | 0.04% | +59.3% |
Q2 2017 | $106,000 | +3.9% | 12,568 | +9.6% | 0.03% | -6.9% |
Q1 2017 | $102,000 | -2.9% | 11,465 | -5.4% | 0.03% | -32.6% |
Q4 2016 | $105,000 | -72.6% | 12,120 | -79.8% | 0.04% | -69.3% |
Q3 2016 | $383,000 | -4.2% | 59,989 | +5.9% | 0.14% | +57.3% |
Q2 2015 | $400,000 | +6.7% | 56,657 | +13.9% | 0.09% | -13.6% |
Q1 2015 | $375,000 | +237.8% | 49,735 | +99.5% | 0.10% | +13.2% |
Q1 2014 | $111,000 | – | 24,924 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |